7th Annual Pricing, Reimbursement and Market Access in Pharma
|Event Date/Time: Mar 05, 2012||End Date/Time: Mar 06, 2012|
How successful are you in managing increasingly complex
Market Access environment?
Benchmark the recent policy developments & changes in healthcare systems across major European markets to ensure better access of patients to new drugs. Following six successful annuals, Fleming Europe invites you to the 7th Annual Pricing, Reimbursement & Market Access in Pharma. Yet again we have gathered worldwide Pharmaceutical pricing specialists who will share their knowledge with you. You will have the chance to meet true market leaders, top speakers and real experts from pharmaceutical industry.
FIND YOUR REASON TO ATTEND
Reveal how to develop an effective strategy to succeed in country-specific negotiations for price approval and granting of reimbursement
Explore the concept of risk-sharing to accelerate the market access
Gain critical insights into HTAs & their role in assessments of new drugs
Understand how to deal with the increasing complexity and uncertainty in current pricing & reimbursement environment
Reveal cost-effectiveness measures & the impact on the industry â€“ is the innovation rewarded correctly?
Make market access an integral part of the company & incorporate market access into the entire drugâ€™s life cycle
How can interaction between regulators and payers facilitate access to orphan drugs?
Discover the role of HTAs â€“ the importance of early dialogue with HTA agencies